S
Stereotaxis Inc
AMEX:STXS
Stereotaxis Inc
AMEX:STXS
Price:
1.8
USD
-2.17%
Market Closed
Market Cap:
$175.1m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
S
|
Stereotaxis Inc
AMEX:STXS
|
US |
|
Compagnie De l'odet SE
PAR:ODET
|
FR |
Relative Value
The Relative Value of one STXS stock under the Base Case scenario is 1.36 USD. Compared to the current market price of 1.8 USD, Stereotaxis Inc is Overvalued by 24%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
STXS
Relative Value
Base Case
1.36
USD
Overvaluation 24%
S
Multiples Across Competitors
STXS Competitors Multiples
Stereotaxis Inc Competitors
Stereotaxis Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
S
|
Stereotaxis Inc
AMEX:STXS
|
171.6m USD | 5.3 | -7.5 | -8.4 | -7.7 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
180.7B USD | 4.1 | 27.7 | 15.9 | 21.8 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
167.6B USD | 16.6 | 58.7 | 44.5 | 54.7 | |
| US |
|
Stryker Corp
NYSE:SYK
|
127.2B USD | 5 | 38.7 | 19.8 | 24 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
111.1B USD | 3.1 | 24.1 | 13.3 | 19.4 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
101.1B USD | 5 | 34.9 | 20.5 | 27.6 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
41.4B EUR | 1.8 | 19.6 | 11 | 15.5 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
47.4B USD | 7.8 | 44.2 | 24.3 | 26.6 | |
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
45.5B USD | 10.6 | 42.9 | 30.4 | 33.7 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
44.4B USD | 2 | 25.3 | 10 | 16.9 | |
| US |
|
Resmed Inc
NYSE:RMD
|
33.2B USD | 6.2 | 22.4 | 15.7 | 17.5 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
